Effects of hormone replacement therapy on the endometrium and lipid parameters: A review of randomized clinical trials, 1985 to 1995

American Journal of Obstetrics and Gynecology

Volumn 178, Issue 5, 1998, Pages 1087-1099

  Pickar, J H ^a   Thorneycroft, I ^a   Whitehead, M ^a  

^a WYETH AYERST RESEARCH   (United States)

Author keywords

Endometrial hyperplasia; Estrogen; Hormone replacement therapy; Lipoproteins; Progestin; Review article

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; DESOGESTREL; DYDROGESTERONE; ESTRADIOL VALERATE; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LEVONORGESTREL; LOW DENSITY LIPOPROTEIN; MEDROGESTONE; MEDROXYPROGESTERONE; MEGESTROL; METHYLTESTOSTERONE; NORETHISTERONE; PROGESTERONE; TRIACYLGLYCEROL;

ARTICLE; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031833660     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70553-8     Document Type: Article

References (56)

1. JD Woodruff JH Pickar the Menopause Study Group Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxy-progesterone acetate or conjugated estrogens alone Am J Obstet Gynecol 170 1994 1213 1223
2. Postmenopausal Estrogen/Progestin Interventions Trial Effects of hormone replacement therapy on endometrial histology in postmenopausal women JAMA 275 1996 370 375
3. PR Koninckx JM Lauweryns FJ Comilhe Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation Maturitas 16 1993 97 110
4. AH MacLennan A MacLennan S Wenzel HM Chambers K Eckert Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial Med J Aust 159 1993 102 106
5. Transdermal HRT Investigators Group A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies Int J Fertil 38 1993 5 11
6. PR Clisham NU Cedars G Greendale YS Fu J Gambone HL Judd Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns Obstet Gynecol 79 1992 196 201
7. I Byrjalsen L Thormann B Meinecke BJ Riis C Christiansen Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium Obstet Gynecol 79 1992 523 528
8. PR Clisham D de Ziegler K Lozano HL Judd Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women Obstet Gynecol 77 1991 241 246
9. A Dupont P Dupont L Cusan Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women Maturitas 13 1991 297 311
10. L Weinstein C Bewtra JC Gallagher Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient Am J Obstet Gynecol 162 1990 1534 1542
11. NM Gelfand A Ferenczy A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium Obstet Gynecol 74 1989 398 402
12. P Hovik HP Sundsbak M Gaasemyr L Sandvik Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms Maturitas 11 1989 75 82
13. C Bewtra WT Kable JC Gallagher Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin J Reprod Med 33 1988 205 208
14. SG Prough S Aksel RH Wiebe J Shepherd Continuous estrogen/progestin therapy in menopause Am J Obstet Gynecol 157 1987 1449 1453
15. L Weinstein Efficacy of a continuous estrogen-progestin regimen in the menopausal patient Obstet Gynecol 69 1987 929 932
16. A Volpe F Facchinetti A Grasso F Petraglia D Campanini AR Genazzani Benefits and risks of different hormonal replacement therapies in post-menopausal women Maturitas 8 1986 327 334
17. DR Mishell D Shoupe DL Moyer S Roy MA Page Postmenopausal hormonal replacement with a combination estrogen-progestin regimen for five days per week J Reprod Med 36 1991 351 355
18. LK Hickok C Toomey L Speroff A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women Obstet Gynecol 82 1993 919 924
19. RA Lobo JH Pickar RA Wild B Walsh E Hirvonen the Menopause Study Group Metabolic impact of adding medroxy-progesterone acetate to conjugated estrogen therapy in postmenopausal women Obstet Gynecol 84 1994 987 995
20. Postmenopausal Estrogen/Progestin Interventions Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women JAMA 273 1995 199 208
21. AA Luciano MJ De Souza MP Roy MJ Schoenfeld JC Nulsen CV Halvorson Evaluation of low-dose estrogen and progestin therapy in postmenopausal women: a double-blind, prospective study of sequential versus continuous therapy J Reprod Med 38 1993 207 214
22. AA Luciano RN Turksoy J Carleo JW Hendrix Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy Obstet Gynecol 71 1988 39 43
23. WT Kable JC Gallagher L Nachtigall D Goldgar Lipid changes after hormone replacement therapy for menopause J Reprod Med 35 1990 512 518
24. BB Sherwin MM Gelfand A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids Obstet Gynecol 73 1989 759 766
25. OP Tadmor Y Kleinman R Goldstein YZ Diamant The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women Int J Gynecol Obstet 39 1992 105 110
26. CJ Kim HC Jang DH Cho YK Min Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women Arterioscler Thromb 14 1994 275 281
27. SI Whitcroft D Crook MS Marsh MC Ellerington MI Whitehead JC Stevenson Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations Obstet Gynecol 84 1994 222 226
28. JC Stevenson D Crook IF Godsland B Lees MI Whitehead Oral versus transdermal hormone replacement therapy Int J Fertil 38 Suppl 1 1993 30 35
29. E Farish CD Fletcher DM Hart HTHTC Teo F Alazzawi C Howie The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subtractions in postmenopausal women Acta Endocrinol Copenh 113 1986 123 127
30. CD Fletcher E Farish MM Dagen DM Hart A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy Maturitas 9 1987 253 258
31. CD Fletcher E Farish MM Dagen F Alazzawi D McQueen DM Hart The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women Acta Endocrinol Copenh 117 1988 339 342
32. NC Siddle DK Jesinger MI Whitehead P Turner B Lewis P Prescott Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone Br J Obstet Gynaecol 97 1990 1093 1100
33. EWW Sonnendecker ES Polakow AJS Benade E Simchowitz Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women Am J Obstet Gynecol 160 1989 1128 1134
34. AT Teichmann H Wieland P Cremer B Hinney W Kuhn D Seidel Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations Maturitas 7 1985 343 350
35. N Munk-Jensen LG Ulrich EB Obel SP Nielsen D Edwards H Meinenz Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect on plasma lipoproteins in a two-year placebo-controlled trial Am J Obstet Gynecol 171 1994 132 138
36. LA Mattsson G Samsioe Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen Acta Obstet Gynecol Scand 130 Suppl 1985 53 58
37. E Farish CD Fletcher MM Dagen Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy Br J Obstet Gynaecol 96 1989 358 364
38. J Jensen BJ Riis V StrØm C Christiansen Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women Br J Obstet Gynaecol 94 1987 130 135
39. J Jensen C Christiansen Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women Maturitas 9 1987 259 266
40. T Sporrong M Hellgren G Samsioe LA Mattsson Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women Obstet Gynecol 73 1989 754 758
41. J Jensen BJ Riis V StrØm C Christiansen Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women Maturitas 11 1989 117 128
42. M Tufekci Z Colak H Ozan Y Kimya A Aydinlar Effect of progestogens on estrogen-induced lipoprotein changes Eur J Obstet Gynecol Reprod Biol 49 1993 169 174
43. S Moorjan A Dupont F Labrie Changes in lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with Utrogestan in menopausal women J Clin Endocrinol Metab 73 1991 373 379
44. J Jensen BJ Riis V Strom L Nilas C Christiansen Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women Am J Obstet Gynecol 156 1987 66 71
45. U Marslew K Overgaard BJ Riis C Christiansen Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding Obstet Gynecol 79 1992 202 210
46. M Metka V Hanes G Heytmanek Hormone replacement therapy: lipid responses to continuous combined oestrogen andprogestogen versus oestrogen monotherapy Maturitas 15 1992 53 59
47. J Jensen BJ Riis C Christiansen Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins Br J Obstet Gynaecol 94 1987 136 141
48. UB Lindberg N Crona L Enk G Samsioe G Silfverstolpe Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE) Horm Metab Res 19 1987 222 225
49. RJ Kurman PF Kaminski HJ Norris The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients Cancer 56 1985 403 412
50. J Jensen L Nilas C Christiansen Influence of menopause on serum and lipoproteins Maturitas 12 1990 321 331
51. KA Matthews E Meilahn LH Kuller Menopause and risk factors for coronary heart disease N Engl J Med 321 1989 641 646
52. MJ Stampfer GA Colditz Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence Prev Med 20 1991 47 63
53. E Barrett-Connor TL Bush Estrogen and coronary heart disease in women JAMA 265 1991 1861 1867
54. M Seed F Hoppichler D Reaveley Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia N Engl J Med 322 1990 1494 1499
55. RA Lobo LP(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen Am J Obstet Gynecol 166 1992 1182 1190
56. C Bengtsson C Björkelund L Lapidus L Lissner Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden BMJ 307 1993 1385 1388